FIMM at 15: EMBL in Finland minisymposium

FIMM at 15: EMBL in Finland Minisymposium text and a blue chromosome.


On May 27, 2022 FIMM warmly welcomes EMBL Director General Edith Heard to Finland and celebrates the occasion with an afternoon minisymposium capturing the unique translational impact that FIMM, EMBL and their partners have made in transforming Nordic science towards an international research hub. 

Please join us as we showcase the science and impact and look forward to future opportunities! No registration necessary. Join in Biomedicum Lecture Hall 1 or online via Zoom.

Zoom link:

Passcode: 797638



12.30 Opening words

Mark Daly, FIMM Director

12.35 EMBL’s new Programme and links with Finland

Edith Heard, EMBL Director General

12.55 The first decade of FIMM

Olli Kallioniemi, Director of SciLifeLab and Jaakko Kaprio, FIMM Research Director

13.10 FIMM at 15

Mark Daly, FIMM Director

13.20 Precision cancer research and FIMM

13.20  The FIMM – HUS journey towards precision hematology

           Kimmo Porkka, Professor, Department of Medicine and Caroline Heckman, FIMM Research Director 

13.35  iCAN: digital precision cancer medicine for discoveries and improved treatments

           Tomi Mäkelä, iCAN Executive Officer

13.45  Reflections on FIMM: Kjetil Taskén, Head of Institute of Cancer Research, Oslo University Hospital

13.50 Human genomics for health and disease research and FIMM

13.50  FinnGen: a public-private partnership improving human health through genetic research

            Aarno Palotie, FIMM Research Director, and Mark Daly, FIMM Director 

14:05  Reflections on FIMM: Heiko Runz, Biogen Senior Medical Director, Head of Human Genetics

14.10  Genetic risk of disease and translation opportunities

           Samuli Ripatti, FIMM Vice Director

14.20 Digital diagnostics for precision medicine and FIMM

14.20  Digital diagnostics in the global setting

           Nina Linder, FIMM Senior Researcher and Harrison Kaingu, Kinondo Kwetu Medical Center, Kenya

14.35 Perspectives on the importance of EMBL and FIMM in Finland

14.35  On partnership with FIMM on virus sequencing: Carita Savolainen-Kopra, Chief Specialist, Head of Microbiology Unit, Finnish Institute of Health and Welfare 

14.40  Marja Makarow, President of Academia Europaea 

14.50  Anita Lehikoinen, Permanent Secretary, Ministry of Education and Culture

14.55  Sirpa Nuotio, EMBL Council Delegate, Senior Science Adviser, Academy of Finland

15.00  Kai Simons, Emeritus Director Max Planck Institute for Molecular Cell Biology and Genetics, CEO Lipotype GmbH     

15.10  Jouni Hirvonen, University of Helsinki Vice Rector for Research (TBC) 

15.15  FIMM Visiting Professor Jonathan Knowles

15.25 Closing words by Mark Daly, FIMM Director

15.30 Reception 

Logos of FIMM, EMBL and Nordic EMBL Partnership for Molecular Medicine.